AgHbs Negativation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B (NCT01172392) | ANRS, Emerging Infectious Diseases | 2011-01-01 |
Track AgHbs Negativation automatically
Every clearance here is in the API, with alerts when new ones post.